FierceBiotech
A roundup article on the data readout from our Phase 2/3 RT001 study in INAD was published by FierceBiotech. The piece does an excellent job summarizing the study results and discussing the next steps. Link to the article.
You are leaving Retrotope’s website. Retrotope does not guarantee the accuracy or completeness of the information contained on any third-party sites, nor does it endorse any of the opinions or information contained on those sites. Please click CONFIRM to continue.
CONFIRM